CAUTION: LymphoDrain technology is under investigational use only and not available for commercial distribution.
Lymphedema is a chronic condition resulting in a local swelling, often of one arm or one leg, caused by the build- up of lymph under the skin.
Local swelling (often of one limb), discomfort and/or pain, recurring skin infections.
> 10 million patients with lymphedema in Europe and USA
No existing cure
The first permanent active implant for lymphedema therapy.
LymphoDrain™ allows for continuous lymph drainage in the subcutaneous tissue.
LymphoDrain™ the world’s first implantable device for lymphdema.
Lymphatica Medtech SA is a medical device company committed to significantly improve the well-being of patients suffering from lymphatic diseases with innovative products.
Lymphatica gets the Swiss Accelerator: CHF 2.5 Million to accelerate market entry
April 28th , 2023
Lymphatica Medtech has obtained the support of Innosuisse in the frame of the Swiss Accelerator: a grant CHF 2.5 million to finance the LyBRA project: Lymphatic Bypass for Recirculation of Accumulated fluids in leg…
LymphoPilot study reached its halfway with promising preliminary results
December 15th , 2022
The study, which includes a 2 months implantation period of our device, is being conducted at the Lausanne University Hospital (link). As of today, the study was completed by 6 upper limb lymphedema patients …